Finding 994130 (2022-006)

Significant Deficiency
Requirement
C
Questioned Costs
-
Year
2022
Accepted
2023-06-28
Audit: 312164
Auditor: Eide Bailly LLP

AI Summary

  • Core Issue: Significant deficiency in internal controls over cash management for federal grants, specifically regarding advance payments not being placed in interest-bearing accounts.
  • Impacted Requirements: Compliance with Uniform Guidance and 2 CFR section 200.305, which mandates that non-federal entities must manage cash advances appropriately.
  • Recommended Follow-Up: Conduct a thorough review of cash management policies to ensure compliance with federal requirements and improve oversight and understanding of the necessary controls.

Finding Text

2022-006 Department of State ? Bureau of Population, Refugees, and MigrationFederal Financial Assistance Listing #19.517, Overseas Refugee Assistance Programs for Africa Agency for International DevelopmentDepartment of State - Federal Financial Assistance Listing #98.001, USAID Foreign Assistance for Programs OverseasCash ManagementType of Finding: Significant Deficiency in Internal Control over ComplianceGrant Award Number: Affects all grant awards included under Federal Financial Assistance Listing #19.517 on the Schedule, and award number 720BHA22GR00046 under Federal Financial Assistance Listing #98.001 on the Schedule.Criteria: Uniform Guidance and 2 CFR section 200.305 sets forth the advance payments? standards non-federal entities, other than states, must follow when operating federal programs and the requirement that cash advances be placed in an interest-bearing account. CVT?s internal control structure should be designed to properly place funds received as cash advances are placed in an interest-bearing account.Condition: CVT does not have internal control system designed to ensure advance payments are placed in an interest-bearing account.Cause: Controls were not adequately designed due to lack of oversight, awareness, or understanding of all of the specific requirements under the Uniform Guidance and applicable CFR sections.Effect: Risk of interest income that should be earned and reported.Questioned Costs: None reportedContext/Sampling: For Federal Financial Assistance Listing #19.517, a nonstatistical sample of 6 requests out of 31 total requests were selected for testing. For Federal Financial Assistance Listing #98.001, a nonstatistical sample of 4 requests out of 17 total requests were selected for testing.Repeat Finding from Prior Year: NoRecommendation: We recommend management complete an extensive review over cash management policies to make sure requirements under the CFR section are met.Views of Responsible Officials: Management agrees with this finding.

Categories

Cash Management Internal Control / Segregation of Duties Significant Deficiency Matching / Level of Effort / Earmarking

Other Findings in this Audit

  • 417661 2022-001
    Significant Deficiency Repeat
  • 417662 2022-001
    Significant Deficiency Repeat
  • 417663 2022-001
    Significant Deficiency Repeat
  • 417664 2022-001
    Significant Deficiency Repeat
  • 417665 2022-001
    Significant Deficiency Repeat
  • 417666 2022-001
    Significant Deficiency Repeat
  • 417667 2022-001
    Significant Deficiency Repeat
  • 417668 2022-001
    Significant Deficiency Repeat
  • 417669 2022-002
    Material Weakness
  • 417670 2022-002
    Material Weakness
  • 417671 2022-002
    Material Weakness
  • 417672 2022-002
    Material Weakness
  • 417673 2022-002
    Material Weakness
  • 417674 2022-002
    Material Weakness
  • 417675 2022-002
    Material Weakness
  • 417676 2022-002
    Material Weakness
  • 417677 2022-004
    Significant Deficiency
  • 417678 2022-004
    Significant Deficiency
  • 417679 2022-004
    Significant Deficiency
  • 417680 2022-004
    Significant Deficiency
  • 417681 2022-004
    Significant Deficiency
  • 417682 2022-004
    Significant Deficiency
  • 417683 2022-004
    Significant Deficiency
  • 417684 2022-004
    Significant Deficiency
  • 417685 2022-006
    Significant Deficiency
  • 417686 2022-006
    Significant Deficiency
  • 417687 2022-006
    Significant Deficiency
  • 417688 2022-006
    Significant Deficiency
  • 417689 2022-006
    Significant Deficiency
  • 417690 2022-006
    Significant Deficiency
  • 417691 2022-006
    Significant Deficiency
  • 417692 2022-006
    Significant Deficiency
  • 417693 2022-001
    Significant Deficiency Repeat
  • 417694 2022-001
    Significant Deficiency Repeat
  • 417695 2022-001
    Significant Deficiency Repeat
  • 417696 2022-003
    Significant Deficiency
  • 417697 2022-003
    Significant Deficiency
  • 417698 2022-003
    Significant Deficiency
  • 417699 2022-004
    Significant Deficiency
  • 417700 2022-004
    Significant Deficiency
  • 417701 2022-004
    Significant Deficiency
  • 417702 2022-005
    Significant Deficiency
  • 417703 2022-006
    Significant Deficiency
  • 994103 2022-001
    Significant Deficiency Repeat
  • 994104 2022-001
    Significant Deficiency Repeat
  • 994105 2022-001
    Significant Deficiency Repeat
  • 994106 2022-001
    Significant Deficiency Repeat
  • 994107 2022-001
    Significant Deficiency Repeat
  • 994108 2022-001
    Significant Deficiency Repeat
  • 994109 2022-001
    Significant Deficiency Repeat
  • 994110 2022-001
    Significant Deficiency Repeat
  • 994111 2022-002
    Material Weakness
  • 994112 2022-002
    Material Weakness
  • 994113 2022-002
    Material Weakness
  • 994114 2022-002
    Material Weakness
  • 994115 2022-002
    Material Weakness
  • 994116 2022-002
    Material Weakness
  • 994117 2022-002
    Material Weakness
  • 994118 2022-002
    Material Weakness
  • 994119 2022-004
    Significant Deficiency
  • 994120 2022-004
    Significant Deficiency
  • 994121 2022-004
    Significant Deficiency
  • 994122 2022-004
    Significant Deficiency
  • 994123 2022-004
    Significant Deficiency
  • 994124 2022-004
    Significant Deficiency
  • 994125 2022-004
    Significant Deficiency
  • 994126 2022-004
    Significant Deficiency
  • 994127 2022-006
    Significant Deficiency
  • 994128 2022-006
    Significant Deficiency
  • 994129 2022-006
    Significant Deficiency
  • 994131 2022-006
    Significant Deficiency
  • 994132 2022-006
    Significant Deficiency
  • 994133 2022-006
    Significant Deficiency
  • 994134 2022-006
    Significant Deficiency
  • 994135 2022-001
    Significant Deficiency Repeat
  • 994136 2022-001
    Significant Deficiency Repeat
  • 994137 2022-001
    Significant Deficiency Repeat
  • 994138 2022-003
    Significant Deficiency
  • 994139 2022-003
    Significant Deficiency
  • 994140 2022-003
    Significant Deficiency
  • 994141 2022-004
    Significant Deficiency
  • 994142 2022-004
    Significant Deficiency
  • 994143 2022-004
    Significant Deficiency
  • 994144 2022-005
    Significant Deficiency
  • 994145 2022-006
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.604 Assistance for Torture Victims $428,936
19.519 Overseas Refugee Assistance Program for Near East and South Asia $268,828
93.958 Block Grants for Community Mental Health Services $137,241
98.001 Usaid Foreign Assistance for Programs Overseas $97,304
16.575 Crime Victim Assistance $63,345
19.345 International Programs to Support Democracy, Human Rights and Labor $28,025
93.671 Family Violence Prevention and Services/domestic Violence Shelter and Supportive Services $22,605
19.990 International Justice and Accountability Programming $17,636
93.498 Provider Relief Fund $11,000
19.517 Overseas Refugee Assistance Programs for Africa $7,613